SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
Rhea-AI Summary
SI-BONE (Nasdaq: SIBN) will report fourth-quarter and full-year 2025 financial results after market close on February 23, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET. A live webcast will be available on the company’s Investors page and archived for at least 90 days.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
SIBN was up 0.18% with mixed peer moves: TNDM +1.01%, AVNS +1.58%, OFIX +2.13%, AXGN -0.48%, ZIMV 0%. No coordinated sector momentum flagged in scanners.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Prelim 2025 results | Positive | -12.6% | Preliminary Q4 and FY 2025 revenue and cash figures with solid growth. |
| Nov 18 | Conference appearance | Neutral | +1.3% | Announcement of presentation at Piper Sandler healthcare conference with webcast. |
| Nov 10 | Q3 2025 earnings | Positive | -0.6% | Strong Q3 revenue growth, margin expansion, positive EBITDA, raised guidance. |
| Nov 10 | Q2 2025 earnings | Positive | -0.6% | Q2 revenue growth over 21% YoY and improved profitability metrics and guidance. |
| Oct 20 | Earnings date set | Neutral | +2.0% | Notification of Q3 2025 earnings release timing and conference call details. |
Recent fundamental positives, including guidance raises and strong growth, have often seen muted or negative next-day price reactions, while neutral event announcements sometimes coincided with small gains.
Over the last few months, SIBN has reported multiple growth milestones. Q3 2025 results showed $48.7M revenue, 20.6% YoY growth, margin improvement, and raised 2025 guidance to $198M–$200M. Preliminary Q4 and full-year 2025 revenue released on Jan 12, 2026 also highlighted double-digit growth and cash generation, yet the stock fell 12.57% the next day. Prior earnings-date notifications and conference appearances produced modest positive moves. Today’s earnings-date announcement fits this pattern of routine communication ahead of final audited results.
Market Pulse Summary
This announcement sets the timetable for SI-BONE’s Q4 and full-year 2025 results on February 23, 2026, with a conference call at 1:30 p.m. PT / 4:30 p.m. ET and a webcast replay available for at least 90 days. It follows preliminary 2025 figures and prior guidance raises, which frame expectations for the full release. Investors may focus on whether final audited numbers, updated outlook, and cash trends support the growth trajectory highlighted in earlier updates.
AI-generated analysis. Not financial advice.
SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, February 23, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/zfxy6yox. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is the global leader in developing procedural solutions to address clinical challenges associated with compromised bone. SI-BONE's expertise in additive manufacturing has resulted in a technology platform with market-leading applications in SI joint fusion, adult spinal deformity and pelvic trauma. Since 2009, SI-BONE has supported physicians in performing a total of over 140,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including four randomized controlled trials and over 200 peer reviewed publications.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.
Marnelli.delcastillo@si-bone.com
650-271-7515
FAQ
When will SI-BONE (SIBN) report Q4 and full-year 2025 results?
How can investors access the SI-BONE (SIBN) earnings call on February 23, 2026?
What time is the SI-BONE (SIBN) conference call for the 2025 results?
Will SI-BONE (SIBN) make a replay of the February 23, 2026 webcast available?
